immortality countdown
日本語
Public Beta

The countdown model and news pipeline are under development. Scores are model inputs and may change as evidence is reviewed.

A provisional longevity estimate

Immortality Countdown

66YEARS

Until medical progress may begin to outrun biological aging.

Median of 20,000 simulations — central estimate 2092, 80% interval 2061–2172. 94% of runs reach it at all.

Why 66 years? →Methodology
When progress outpaces aging
Conceptual diagram of longevity escape velocityA modest gray line labeled Passage of time / aging rises steadily. A solid teal curve labeled Medical progress starts gradually, then steepens exponentially and crosses the gray line at a point labeled LEV. The chart illustrates the idea of medical progress outpacing aging. It is not a forecast or measured data.Healthy lifespan gainedPassage of time / agingTimeMedical progressLEV

Illustrative concept — not a forecast or measured data.

Regulatory & Deployment Readiness

Model input · Last reviewed 2026-08-19

15 / 100

Eight Fields of Progress

Current model readiness scores · 8 of 8 fields scored

Rejuvenation & Regeneration

40

Biomarkers & Diagnostics

44

Geroscience Drugs & Trials

33

Gene Therapy & Delivery

36

AI Drug Discovery

52

Organ Replacement & Biofabrication

38

Immune Engineering & Cancer Control

45

Enabling Technology & Automation

50

Explore all eight fields →

Latest Signal

Biomarkers & DiagnosticsEvidence C

Deep-learning tissue clocks map aging across 40 human tissue types

What happened
Researchers analyzed 25,712 histopathology whole-slide images from 40 tissue types across 983 GTEx donors and trained models that estimated tissue-specific biological age. The resulting signatures were associated with established aging markers and disease-relevant organ aging in independent cohorts.
What it means
Tissue architecture may provide another scalable way to measure organ-specific aging, potentially strengthening biomarker validation and future trial endpoints.
Caveat
This is observational biomarker research, not an intervention trial. The models identify age-related signatures and disease associations; they do not show that changing a tissue-clock score improves health or lifespan.
Nature Medicine →DOI 10.1038/s41591-026-04566-5

Latest Verified Updates

Rejuvenation & RegenerationEvidence C

Physical activity is associated with later menopause and delays ovarian aging in mice

What happened
Cross-sectional analyses of 152,435 UK Biobank participants and 12,418 NHANES participants linked higher physical activity with a less advanced reproductive-aging profile. In mice, physical activity delayed ovarian aging, with adiponectin signaling implicated in the effect.
What it means
The study adds human observational and animal mechanistic evidence that physical activity may influence reproductive aging, while identifying adiponectin signaling as a pathway worth following.
Caveat
The human analyses are cross-sectional and cannot establish that physical activity delayed menopause. The causal and mechanistic evidence comes from mice, so this should not be generalized to whole-body human rejuvenation.
Nature Aging →DOI 10.1038/s43587-026-01177-0
Immune Engineering & Cancer ControlEvidence D

Systemic TNF signaling drives intestinal stem-cell aging in mice

What happened
Using heterochronic parabiosis, mouse experiments and organoids, researchers linked the aged systemic environment to impaired intestinal stem-cell function through TNF-TNFR1 signaling, mitochondrial dysfunction and reduced fatty-acid oxidation.
What it means
The work supports inflammaging as a causal contributor to tissue stem-cell decline and identifies TNF-TNFR1 signaling and cellular metabolism as mechanisms worth tracking.
Caveat
The causal experiments are in mice and organoids. They do not establish that TNF blockade or anti-inflammatory drugs slow human aging, and such treatments can carry clinically important risks.
Nature Aging →DOI 10.1038/s43587-026-01170-7